The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Xylocaine(R) -Mpf (Lidocaine Hci And Epinephrine)
Xylocaine(R) -Mpf (Lidocaine Hci And Epinephrine) · LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL · Injection, Solution · Epidural; Infiltration; Intracaudal; Perineural · HF Acquisition Co LLC, DBA HealthFirst
NDC 51662-1405-01 · 30 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- HF Acquisition Co LLCUnited Statesrelabel
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA006488
- TE code
- AP
- Approval date
- Jan 1, 1982
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Xylocaine(R) -Mpf (Lidocaine Hci And Epinephrine) (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | LIDOCAINE HYDROCHLORIDE ANHYDROUS .005 mg/mL; EPINEPHRINE BITARTRATE 10 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | EPINEPHRINE BITARTRATE .005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Xylocaine(R) -Mpf (Lidocaine Hci And Epinephrine) — NDC 51662-1405-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51662140501.
Free to cite with attribution — see how the data is put together.